EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Trends in antifungal research



Trends in antifungal research



Exs 89: 55-68



With the increasing use of aggressive immunosuppressive therapies in the management of a variety of patient populations, the continuing presence of the AIDS pandemic and the therapeutic advances employed in critical care settings, an increasing number of serious fungal infections are being encountered by today's practicing clinicians. Traditionally, antifungal drug therapy has been delivered by means of intravenous infusion, oral administration, or topical application. Recently, a number of alternative routes of antifungal drug delivery have been developed and investigated, and the traditional means of antifungal administration have been improved to facilitate the therapeutic use of new and reformulated antifungal agents. Organized based on the route of administration, this chapter reviews these advances in antifungal drug delivery.

(PDF 0-2 workdays service: $29.90)

Accession: 035985200

Download citation: RISBibTeXText

PMID: 10997282



Related references

Antifungal agents--recent trends in development and progress in research of action mechanism. Nihon Rinsho. Japanese Journal of Clinical Medicine 49(9): 2176-2185, 1991

Results of antifungal susceptibility testing of Candida species and trends of antifungal use in Niigata university medical and dental hospital. Rinsho Byori. Japanese Journal of Clinical Pathology 58(7): 658-663, 2010

Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. Journal of Clinical Microbiology 46(3): 842-849, 2008

Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method. Journal of Clinical Microbiology 39(11): 4181-4183, 2001

Research on antibacterial and antifungal agents 4. synthesis and antifungal activity of econazole analogs with a pyrrole structure. Farmaco Edizione Scientifica 40(5): 315-324, 1985

Research on antibacterial and antifungal agents 16 Synthesis and antifungal activities of 1- benzylimidazole derivatives and related 2-naphthyl isomers. European Journal of Medicinal Chemistry 27(7): 693-699, 1992

Research on antibacterial and antifungal compounds viii. synthesis and antifungal activity of pyrrol derivatives similar to trichostatin a. Farmaco Edizione Scientifica 42(12): 893-904, 1987

Research on antibacterial and antifungal agents. 16. Synthesis and antifungal activities of 1-imidazole derivatives and related 2-naphthyl isomers. European Journal of Medicinal Chemistry 27(7): 693-699, 1992

National institute of health and medical research colloquium vol 147 modern trends in aging research international inserm eurage symposium on modern trends in aging research gerontology and geriatrics paris france march 1986. 1987

Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. Journal of Clinical Microbiology 51(8): 2571-2581, 2014

Antifungal drugs. First International Conference on Drug Research in Immunological and Infectious Diseases. Antifungal Drugs: Synthesis, Preclinical and Clinical Evaluation held in Garden City, New York, USA, October 8-10, 1987. Annals of the New York Academy of Sciences 544: 1-613, 1988

Pediatric antifungal utilization: new drugs, new trends. Pediatric Infectious Disease Journal 27(12): 1083-1088, 2008

Trends in development of new antifungal agents in Japan. Nihon Rinsho. Japanese Journal of Clinical Medicine 66(12): 2384-2387, 2009